Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing bisacodyl (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bisacodyl (substance) |
Inferred relationship |
Some |
1 |
Accidental bisacodyl poisoning (disorder) |
Causative agent (attribute) |
False |
Bisacodyl (substance) |
Inferred relationship |
Some |
|
Intentional bisacodyl poisoning |
Causative agent (attribute) |
False |
Bisacodyl (substance) |
Inferred relationship |
Some |
|
intoxication par le bisacodyl d'intention indéterminée |
Causative agent (attribute) |
False |
Bisacodyl (substance) |
Inferred relationship |
Some |
1 |
Bisacodyl adverse reaction |
Causative agent (attribute) |
True |
Bisacodyl (substance) |
Inferred relationship |
Some |
1 |
Allergy to bisacodyl |
Causative agent (attribute) |
False |
Bisacodyl (substance) |
Inferred relationship |
Some |
|
Bisacodyl overdose |
Causative agent (attribute) |
True |
Bisacodyl (substance) |
Inferred relationship |
Some |
1 |
Accidental bisacodyl overdose |
Causative agent (attribute) |
True |
Bisacodyl (substance) |
Inferred relationship |
Some |
1 |
Intentional bisacodyl overdose |
Causative agent (attribute) |
True |
Bisacodyl (substance) |
Inferred relationship |
Some |
1 |
surdose de bisacodyl d'intention indéterminée |
Causative agent (attribute) |
False |
Bisacodyl (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely bisacodyl 5 milligram/1 each gastro-resistant oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bisacodyl (substance) |
Inferred relationship |
Some |
|
Product containing precisely bisacodyl 10 milligram/1 each conventional release rectal suppository (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bisacodyl (substance) |
Inferred relationship |
Some |
|
Bisacodyl 5mg pediatric suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bisacodyl (substance) |
Inferred relationship |
Some |
|
Poisoning by bisacodyl |
Causative agent (attribute) |
True |
Bisacodyl (substance) |
Inferred relationship |
Some |
1 |
Bisacodyl metabolites (substance) |
Is a |
False |
Bisacodyl (substance) |
Inferred relationship |
Some |
|
Urine bisacodyl level (procedure) |
Component |
False |
Bisacodyl (substance) |
Inferred relationship |
Some |
2 |
Bisacodyl tannex |
Is a |
True |
Bisacodyl (substance) |
Inferred relationship |
Some |
|
Accidental bisacodyl poisoning (disorder) |
Causative agent (attribute) |
True |
Bisacodyl (substance) |
Inferred relationship |
Some |
1 |
Intentional bisacodyl poisoning |
Causative agent (attribute) |
True |
Bisacodyl (substance) |
Inferred relationship |
Some |
1 |
Urine bisacodyl metabolites level |
Component |
False |
Bisacodyl (substance) |
Inferred relationship |
Some |
|
Product containing bisacodyl and macrogol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bisacodyl (substance) |
Inferred relationship |
Some |
1 |
Allergy to bisacodyl |
Causative agent (attribute) |
True |
Bisacodyl (substance) |
Inferred relationship |
Some |
1 |
Bisacodyl 5 mg rectal suppository |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Bisacodyl (substance) |
Inferred relationship |
Some |
1 |
Product containing bisacodyl in rectal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bisacodyl (substance) |
Inferred relationship |
Some |
1 |
Product containing bisacodyl in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bisacodyl (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely bisacodyl 5 milligram/1 each gastro-resistant oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Bisacodyl (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely bisacodyl 5 milligram/1 each gastro-resistant oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Bisacodyl (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely bisacodyl 10 milligram/1 each conventional release rectal suppository (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Bisacodyl (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely bisacodyl 10 milligram/1 each conventional release rectal suppository (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Bisacodyl (substance) |
Inferred relationship |
Some |
1 |
Bisacodyl 5 mg rectal suppository |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Bisacodyl (substance) |
Inferred relationship |
Some |
1 |
Bisacodyl only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bisacodyl (substance) |
Inferred relationship |
Some |
1 |
Bisacodyl and macrogol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bisacodyl (substance) |
Inferred relationship |
Some |
1 |
Bisacodyl only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bisacodyl (substance) |
Inferred relationship |
Some |
1 |
Bisacodyl only product in rectal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bisacodyl (substance) |
Inferred relationship |
Some |
1 |
Bisacodyl 2 mg/mL rectal suspension |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Bisacodyl (substance) |
Inferred relationship |
Some |
1 |
Bisacodyl 2 mg/mL rectal suspension |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Bisacodyl (substance) |
Inferred relationship |
Some |
1 |
Urine bisacodyl level (procedure) |
Component |
True |
Bisacodyl (substance) |
Inferred relationship |
Some |
1 |